Correlation Between NYSE Composite and Serina Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Serina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Serina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Serina Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Serina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Serina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Serina Therapeutics.
Diversification Opportunities for NYSE Composite and Serina Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NYSE and Serina is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Serina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Serina Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Serina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Serina Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Serina Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Serina Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.09 times more return on investment than Serina Therapeutics. However, NYSE Composite is 11.43 times less risky than Serina Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Serina Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,491,412 in NYSE Composite on September 19, 2024 and sell it today you would earn a total of 407,284 from holding NYSE Composite or generate 27.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Serina Therapeutics
Performance |
Timeline |
NYSE Composite and Serina Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Serina Therapeutics
Pair trading matchups for Serina Therapeutics
Pair Trading with NYSE Composite and Serina Therapeutics
The main advantage of trading using opposite NYSE Composite and Serina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Serina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Serina Therapeutics will offset losses from the drop in Serina Therapeutics' long position.NYSE Composite vs. Chipotle Mexican Grill | NYSE Composite vs. Cracker Barrel Old | NYSE Composite vs. Shake Shack | NYSE Composite vs. Integral Ad Science |
Serina Therapeutics vs. Lipocine | Serina Therapeutics vs. Waste Management | Serina Therapeutics vs. Artisan Partners Asset | Serina Therapeutics vs. SEI Investments |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |